SpineThera Featured at BIO - NIH SBIR Innovation Zone

SpineThera, a privately held, pre-clinical stage pharmaceutical company, has been selected to participate in the National Institutes of Health SBIR Innovation Zone at the BIO International convention to be held in San Francisco, June 6-9, 2016.

About BIO: As the world's largest biotechnology conference and exhibition, this annual event attracts 15,000 biotech leaders from 65 countries and covers the wide spectrum of life science innovations and application areas including drug discovery, bio manufacturing, genomics, biofuels, nanotechnology, cell therapy, and more.

About the BIO Innovation Zone: The NIH and NSF have continued their partnership with BIO, where nearly 100 of the most promising SBIR/STTR grantees will showcase and discuss their technologies in the exciting Innovation Zone, a premier partnering opportunity, at the BIO International Convention on June 6-9, 2016, in San Francisco, CA.

Mr. Jeff Missling, CEO of SpineThera said, "We are grateful for the support of NIH who previously funded our Phase 1 SBIR grant and now is providing this opportunity to be featured at BIO 2016. Emily Meyering, our Director of R&D, and I are looking forward to telling SpineThera's story at BIO and welcome invitations for 1:1 meetings with interested parties."